Catalyst
Slingshot members are tracking this event:
Vanda Pharmaceuticals (VNDA) Phase 2 HETLIOZ trial on Jet Lag symptoms expected to release results in Q1 2018
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| VNDA | Community voting in process | |||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 05, 2018
Occurred Source:
http://phx.corporate-ir.net/phoenix.zhtml?c=196233&p=irol-newsArticle&ID=2336085
Related Projects
Related Keywords
Hetlioz, Phase 2 Clinical Trial Data, Jet Lag
